Table 2.
- | - | RC | MD | LY | CO | F (p) | Bonferroni (p<0.05) |
---|---|---|---|---|---|---|---|
- | n=6 | n=6 | n=6 | n=6 | - | - | |
Db/db mice | |||||||
Antioxidant capacity μM Trolox equivalents |
Adipose Tissue+ | 405.02 | 473.59 | 615.67 | 332.84 | --- (0.001+) | RC vs LY, CO vs LY |
Plasma++ | 706.90± 22.14 |
639.20± 18.80 |
730.35± 41.00 |
379.27± 35.60 |
9.341 (0.000) | RC vs CO, MD vs CO, LY vs CO | |
Lipid peroxidation μM MDA equivalents |
Adipose Tissue++ | 0.43± 0.07 |
0.44± 0.03 |
0.45± 0.08 |
0.60± 0.04 |
2.624 (0.062) | NS |
Plasma | 0.08± 0.01 |
0.08± 0.01 |
0.08± 0.01 |
0.10± 0.01 |
1.437 (0.245) | NS | |
CD1 mice | |||||||
Antioxidant capacity, μM Trolox equivalents |
Adipose Tissue++ | 487.31± 64.43 |
424.32± 65.67 |
545.48± 81.35 |
378.81± 53.84 |
0.883 (0.457) | NS |
Plasma++ | 1103.49± 79.78 |
930.64± 32.23 |
1132.97± 85.75 |
804.12± 26.29 |
8.679 (0.000) | RC vs CO, LY vs CO | |
Lipid peroxidation, μM MDA Equivalents |
Adipose Tissue++ | 0.07± 0.01 |
0.08± 0.01 |
0.06± 0.01 |
0.07± 0.01 |
0.171 (0.915) | NS |
Plasma++ | 0.42± 0.11 |
0.46± 0.07 |
0.44± 0.02 |
0.46± 0.11 |
1.046 (0-382) | NS |
+ Data are presented as median (p50); Kruskal-Wallis H Test as data were not normally distributed.
++ Data are presented as means ± SD; One-way ANOVA for comparison of differences between all groups.
NS: Non-significant.